Latest News in the pharma Industry

Biopharma News

Pharmaron pays $118.7 million for AbbVie UK biomanufacturing site

Pharmaron pays $118.7 million for AbbVie UK biomanufacturing site

1 Mar 2021

This transaction complements Pharmaron’s recent acquisition of Absorption Systems in the US for building an integrated cell and gene therapy services platform

Read more 
Catalent takes double action to boost cell and gene therapy services

Catalent takes double action to boost cell and gene therapy services

23 Feb 2021

The company acquires a pDNA CDMO and launches pDNA development and manufacturing services at its Rockville, Maryland facility

Read more 
BMS expands global footprint with new cell therapy manufacturing facility

BMS expands global footprint with new cell therapy manufacturing facility

23 Feb 2021

The new site will be equipped to enable quick ramp-up of capacity for clinical and commercial cell therapy products

Read more 
Catalent secures softgels commercial supply agreement with Aurinia

Catalent secures softgels commercial supply agreement with Aurinia

22 Feb 2021

The CDMO will manufacture recently FDA-approved Lupkynis as a softgel dosage form at its St Petersburg, Florida, facility

Read more 
MaxiVAX and Minaris strike immunotherapy manufacturing partnership deal

MaxiVAX and Minaris strike immunotherapy manufacturing partnership deal

22 Feb 2021

The manufacturing agreement includes process development for scale-up and technology transfer with the goal of supplying Phase II and III clinical studies

Read more 
Novavax agrees huge supply deal with Gavi for 1.1 billion doses of COVID-19 vaccine

Novavax agrees huge supply deal with Gavi for 1.1 billion doses of COVID-19 vaccine

19 Feb 2021

Biotech will manufacture shots with partner SII for equitable vaccine distribution programme, COVAX

Read more 
Dermapharm expands COVID-19 vaccine production capacity at ex-Merck site

Dermapharm expands COVID-19 vaccine production capacity at ex-Merck site

15 Feb 2021

The company's additional production capacities are scheduled to go into operation in May 2021

Read more 
Catalent secures Trizell cell therapy development and manufacturing contract

Catalent secures Trizell cell therapy development and manufacturing contract

8 Feb 2021

The agreement allows the CDMO to "stay on the forefront of emerging indications and cell types"

Read more 
Clinical knowledge deficits to slow biotech development, warns Europital

Clinical knowledge deficits to slow biotech development, warns Europital

8 Feb 2021

The CRO predicts investment communities will come to the rescue of small and medium companies looking to advance their candidates

Read more 
Argonaut Manufacturing Services opens custom controls & standards facility

Argonaut Manufacturing Services opens custom controls & standards facility

2 Feb 2021

The CMO has designed the new service to alleviate manufacturing challenges associated with positive controls and nucleic acid templates

Read more 
Almac expands global biologics testing services with mass spectrometry investment

Almac expands global biologics testing services with mass spectrometry investment

26 Jan 2021

The company's £0.5 million investment in mass spectrometry support accelerates biologics development and approval

Read more 
EU delivers export threat after AstraZeneca cuts Q1 vaccine supply

EU delivers export threat after AstraZeneca cuts Q1 vaccine supply

26 Jan 2021

European Commission pressures pharma firm over reduced shipments amid criticism for slow vaccine rollout across block

Read more